Health Alzheimer's Disease study plans to study 2,000 volunteers' brain scans and blood work to identify biomarkers of ...

Nearly one thousand people attended the Lexington Walk to End Alzheimer's in support of finding a cure for the disease.

Roche drops a third Alzheimer’s candidate this year, terminating a partnership with UCB just four years after agreeing to ...

Alzheimer's is a brain disease that causes memory loss and thinking problems. It gets worse over time and is the most common ...

Within Tibetan medicine, the medicinal herb Terminalia chebula (T. chebula) is well-known for its extensive therapeutic ...

There is no cure for Alzheimer’s disease, but treatments can help manage symptoms. Kisunla is a newer treatment that works to slow down how fast Alzheimer’s progresses. It contains an antibody ...

A recent study suggests that a drug approved for the treatment of seizures may also help treat Alzheimer's in people who do ...

Rensselaer Polytechnic Institute (RPI) has been awarded two grants by the National Institute on Aging (NIA) to train graduate ...

Lexeo Therapeutics, Inc. (Nasdaq: LXEO), a clinical stage genetic medicine company dedicated to pioneering treatments for genetically defined cardiovascular diseases and APOE4-associated Alzheimer’s ...

Dronabinol is safe and effective for the treatment of Alzheimer disease with agitation (Agit-AD), according to a study ...

Alzheimer's disease might damage the brain in two distinct phases, a new study suggests. An early phase that occurs slowly ...

Neurophet has specialized in developing solutions for diagnosis support, treatment guides, and treatment devices targeting ...